Gregory Kealey

Visionary Education Technology Announces Board Changes

Retrieved on: 
Wednesday, November 30, 2022

Toronto, Canada, Nov. 30, 2022 (GLOBE NEWSWIRE) -- Visionary Education Technology Holdings Group Inc. (the "Company") (NASDAQ: VEDU), a private education provider located in Canada, with subsidiaries in Canada and market partners in China, today announced the board of directors changes, effective on November 22, 2022.

Key Points: 
  • Toronto, Canada, Nov. 30, 2022 (GLOBE NEWSWIRE) -- Visionary Education Technology Holdings Group Inc. (the "Company") (NASDAQ: VEDU), a private education provider located in Canada, with subsidiaries in Canada and market partners in China, today announced the board of directors changes, effective on November 22, 2022.
  • The Companys board of directors (the Board) elected Mr. Marc Kealey as the Companys Chairman of the Board of Directors and a member of the Board to succeed Dr. Thomas Traves, who resigned on November 22, 2022.
  • Additionally, the Board elected Mr. William Chai as the Companys member of the Board, Chairman of the Audit Committee, and member of the Nominating and Corporate Governance Committee, and the Compensation Committee of the Board.
  • AboutVisionary Education Technology Holdings Group Inc.
    Visionary Education Technology Holdings Group Inc., headquartered inToronto, Canada, is a private education provider located inCanada, with subsidiaries in Canada and market partners in China, that offers high-quality education resources to students around the globe.

NeuroSigma Announces Promotion of Dr. Colin Kealey to President

Retrieved on: 
Tuesday, January 11, 2022

LOS ANGELES, Jan. 11, 2022 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a bioelectronic medical device company, today announced the promotion of Dr. Colin Kealey to President.

Key Points: 
  • LOS ANGELES, Jan. 11, 2022 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a bioelectronic medical device company, today announced the promotion of Dr. Colin Kealey to President.
  • We are thrilled to provide Dr. Kealey with appropriate recognition for his leadership and achievements, said Kirk Calhoun, Lead Director of NeuroSigma.
  • We have full confidence in Dr. Kealeys ability to guide NeuroSigma to its next phase of commercial and technological advancement.
  • Dr. Kealey most recently served as NeuroSigmas Vice President of Advanced Development and Medical Affairs.